Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

ClinicalTrials.gov ID: NCT00932893

Public ClinicalTrials.gov record NCT00932893. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 11:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3, Randomized, Open-label Study Of The Efficacy And Safety Of Pf-02341066 Versus Standard Of Care Chemotherapy (Pemetrexed Or Docetaxel) In Patients With Advanced Non-small Cell Lung Cancer (Nsclc) Harboring A Translocation Or Inversion Event Involving The Anaplastic Lymphoma Kinase (Alk) Gene Locus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3 trial comparing the safety and anti-tumor activity of PF-02341066 versus pemetrexed or docetaxel in patients with advanced non-small cell lung cancer with specific gene profile involving the ALK gene after failure of one previous chemotherapy regimen that included one platinum drug.

Study identification

NCT ID
NCT00932893
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
347 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2009 (Type not available)
Primary completion
Mar 2012 (Actual)
Completion
Jan 2016 (Actual)
Last update posted
Jan 2, 2017

2009 – 2016

United States locations

U.S. sites
119
U.S. states
23
U.S. cities
61
Facility City State ZIP Site status
University of Arkansas for Medical Research, Winthrop Rockefeller Cancer Institute Little Rock Arkansas 72205 —
Comprehensive Blood and Cancer Center Bakersfield California 93309 —
Tower Cancer Research Foundation Beverly Hills California 90211-1850 —
Tower Hematology Oncology Medical Group Beverly Hills California 90211 —
UCSD Medical Center -La Jolla La Jolla California 92037 —
Moores UC San Diego Cancer Center La Jolla California 92093-0698 —
Drug Shipping Address: [IRB# 10-001530] Ronald Reagan UCLA Los Angeles California 90095-6984 —
Ronald Reagan UCLA Medical Center Los Angeles California 90095 —
UCLA Hematology Oncology Los Angeles California 90095 —
UCLA Ophthalmic Oncology Center Los Angeles California 90095 —
University of California-Los Angeles Los Angeles California 90095 —
Ship Drug To : Kevin Kong- University of California, Irvine-Pharmacy Orange California 92868-3298 —
University of California, Irvine-Medical Center Orange California 92868-3298 —
Stanford University-Cancer Center Palo Alto California 94305 —
UC Davis Cancer Center Sacramento California 95817 —
University of California Davis Medical Center Sacramento California 95817 —
UCSD Medical Center- Hillcrest San Diego California 92103 —
Santa Monica-UCLA Medical Center and Orthopaedic Hospital Santa Monica California 90404 —
University of California, Los Angeles Santa Monica California 90404 —
Redwood Regional Medical Group, Inc. Santa Rosa California 95403 —
Drug Shipment: University of Colorado Cancer Center, Anschutz Cancer Pavilion Aurora Colorado 80045 —
University of Colorado Denver (CTRC) Aurora Colorado 80045 —
Unviersity of Colorado Hospital, Anschutz Cancer Pavilion Aurora Colorado 80045 —
Unviersity of Colorado Hospital, Anschutz Inpatient Pavilion Aurora Colorado 80045 —
Kaiser Permanente Denver Colorado 80205 —
Kaiser Permanente Lafayette Colorado 80026 —
Drug Shipping for Yale; C/O Thomas Ferencz, RPh, BCOP New Haven Connecticut 06510 —
Smilow Cancer Hospital at Yale New Haven New Haven Connecticut 06510 —
Clinical Trial Office New Haven Connecticut 06519 —
Yale Cancer Center New Haven Connecticut 06520 —
Memorial Cancer Institute Hollywood Florida 33021 —
Cancer Center of South Florida Foundation, Inc. Lake Worth Florida 33461 —
Memorial Cancer Institute (West) Pembroke Pines Florida 33028 —
H Lee Moffitt Cancer Center & Research Institute Tampa Florida 33612 —
Emory University Hospital Midtown Atlanta Georgia 30308 —
Emory Clinic Atlanta Georgia 30322 —
Emory University Clinic Atlanta Georgia 30322 —
Emory University Hospital Atlanta Georgia 30322 —
Winship Cancer Institution Atlanta Georgia 30322 —
Georgia Cancer Specialists-Administrative Annex Atlanta Georgia 30341 —
Georgia Cancer Specialists - Stemmer Decatur Georgia 30033 —
Georgia Cancer Specialists-Macon Macon Georgia 31217 —
Georgia Cancer Specialists-Kennestone Marietta Georgia 30060 —
Georgia Cancer Specialists Sandy Springs Georgia 30342 —
Cancer Research Center of Hawaii Honolulu Hawaii 96813 —
Hawaii Medical Center East Honolulu Hawaii 96813 —
OnCare Hawaii, Inc. Honolulu Hawaii 96813 —
Rush University Medical Center Chicago Illinois 60612 —
University of Chicago Medical Center Chicago Illinois 60637 —
Ingalls Memorial Hospital (Drug Shipment Only) Harvey Illinois 60426 —
Ingalls Memorial Hospital Harvey Illinois 60426 —
Monroe Medical Associates Harvey Illinois 60426 —
Monroe Medical Associates Tinley Park Illinois 60477 —
Indiana University Hospital Indianapolis Indiana 46202 —
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 —
Ship Drug to: Investigational Drug Services Indianapolis Indiana 46202 —
Wishard Memorial Hospital Indianapolis Indiana 46202 —
Springmill Medical Clinic Indianapolis Indiana 46290 —
Monroe Medical Associates Munster Indiana 46321 —
The Community Hospital Munster Indiana 46321 —
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21231 —
Massachusette General Hospital Boston Massachusetts 02114 —
Massachussetts General Hospital Boston Massachusetts 02114 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Beth Isreal Deaconess Medical Center Boston Massachusetts 02215 —
Dana Farber Cancer Institute Boston Massachusetts 02215 —
DFCI/Pharmacy (Drug Shipment Only) Boston Massachusetts 02215 —
Karmanos Cancer Institute Detroit Michigan 48201 —
Lawrence and Idell Weisberg Cancer Treatment Center Farmington Hills Michigan 48334 —
Siteman Cancer Center City of Saint Peters Missouri 63376 —
Siteman Cancer Center- West County Creve Coeur Missouri 63141 —
Barnes-Jewish Hospital St Louis Missouri 63110-1094 —
Washington University, School of Medicine St Louis Missouri 63110 —
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756-0001 —
NSLIJ Health System/Monter Cancer Center Lake Success New York 11042 —
Memorial Sloan-Kettering Cancer Center: Rockefeller Outpatient Pavilion New York New York 10022 —
Columbia University Medical Center New York New York 10032 —
Memorial Sloan-Kettering Cancer Center New York New York 10065 —
Department of Medicine MSG at SUNY HSC at Syracuse, INC., d/b/a University Physicians Oneida New York 13421 —
Department of Medicine MSG at SUNY HSC at Syracuse, INC., d/b/a University Physicians Oswego New York 13126 —
SUNY Upstate Medical University Syracuse New York 13210-2306 —
Department of Medicine MSG at SUNY HSC at Syracuse, INC., d/b/a University Physicians Syracuse New York 13210 —
Investigational Drug Service, Pharmacy Department, UNC Hospitals Chapel Hill North Carolina 27514 —
UNC Health Care, NC Cancer Hospital Infusion/lnpatient Pharmacy (CHIP) Chapel Hill North Carolina 27514 —
UNC Hospitals Chapel Hill North Carolina 27599-7600 —
Cleveland Clinic Cleveland Ohio 44195 —
The Ohio State University Hospital East Columbus Ohio 43205 —
The Ohio State University James Cancer Hospital and Solove Research Institute Columbus Ohio 43210 —
James Care in Kenny Columbus Ohio 43221 —
Oregon Health and Science University Portland Oregon 97239 —
Penn State Milton S. Hershey Medical Center, Penn State Hershey Cancer Institute Hershey Pennsylvania 17033-0850 —
Abramson Cancer Center of the University of Pennsylvania at Perelman Center for Advanced Medicine Philadelphia Pennsylvania 19104 —
Penn Presbyterian Medical Center Philadelphia Pennsylvania 19104 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
University of Pittsburgh Medical Center-Shadyside Pittsburgh Pennsylvania 15232 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232 —
Vincent Armenio, MD East Providence Rhode Island 02914 —
Pharma Resource East Providence Rhode Island 02915 —
Tennessee Oncology, PLLC Dickson Tennessee 37055 —
Tennessee Oncology, PLLC Franklin Tennessee 37067 —
Tennessee Oncology, PLLC Gallatin Tennessee 37066 —
Tennessee Oncology, PLLC Hermitage Tennessee 37076 —
Tennessee Oncology, PLLC Lebanon Tennessee 37087 —
Tennessee Oncology, PLLC Murfreesboro Tennessee 37130 —
Sarah Cannon Research Institute Nashville Tennessee 37203 (Pharmacy) —
Sarah Cannon Research Institute Nashville Tennessee 37203 —
Tennessee Oncology, PLLC Nashville Tennessee 37203 —
Tennessee Oncology, PLLC Nashville Tennessee 37205 —
Tennessee Oncology, PLLC Nashville Tennessee 37207 —
Tennessee Oncology, PLLC Nashville Tennessee 37211 —
The Vanderbilt Cancer Clinic Nashville Tennessee 37232-5536 —
The Vanderbilt Chemo Pharmacy Nashville Tennessee 37232-7610 —
Tennessee Oncology, PLLC Smyrna Tennessee 37167 —
The University of Texas Houston Texas 77030 —
Swedish Cancer Institute Seattle Washington 98104 —
Seattle Cancer Care Alliance Seattle Washington 98109 —
Investigational Drug Service Seattle Washington 98122 —
Swedish Medical Center Seattle Washington 98122 —
University of Washington Medical Center Seattle Washington 98195 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 145 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00932893, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 2, 2017 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00932893 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →